{
    "organizations": [],
    "uuid": "666f11347e2a6a2eb9825b8f9e27c5e7a1983efb",
    "author": "",
    "url": "https://www.reuters.com/article/brief-soligenix-receives-orphan-drug-des/brief-soligenix-receives-orphan-drug-designation-from-the-european-commission-for-rivax-for-prevention-of-ricin-poisoning-idUSFWN1R40E7",
    "ord_in_thread": 0,
    "title": "BRIEF-Soligenix Receives Orphan Drug Designation From The European Commission For Rivax For Prevention Of Ricin Poisoning",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 22, 2018 / 10:19 AM / Updated 17 minutes ago BRIEF-Soligenix Receives Orphan Drug Designation From The European Commission For Rivax For Prevention Of Ricin Poisoning Reuters Staff 1 Min Read March 22 (Reuters) - Soligenix Inc: * SOLIGENIX RECEIVES ORPHAN DRUG DESIGNATION FROM THE EUROPEAN COMMISSION FOR RIVAXÂ® FOR PREVENTION OF RICIN POISONING Source text for Eikon: Further company coverage:",
    "published": "2018-03-22T12:18:00.000+02:00",
    "crawled": "2018-03-22T12:39:06.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "updated",
        "minute",
        "ago",
        "receives",
        "orphan",
        "drug",
        "designation",
        "european",
        "commission",
        "rivax",
        "prevention",
        "ricin",
        "poisoning",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "soligenix",
        "inc",
        "soligenix",
        "receives",
        "orphan",
        "drug",
        "designation",
        "european",
        "commission",
        "prevention",
        "ricin",
        "poisoning",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}